11/26
02:09 pm
ino
Inovio Pharmaceuticals (NASDAQ:INO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Inovio Pharmaceuticals (NASDAQ:INO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/18
08:05 am
ino
INOVIO to Participate in December Investor Conferences
Medium
Report
INOVIO to Participate in December Investor Conferences
11/14
07:08 pm
ino
Individual investors invested in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) lost 13% last week, institutions remained on the sidelines [Yahoo! Finance]
Medium
Report
Individual investors invested in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) lost 13% last week, institutions remained on the sidelines [Yahoo! Finance]
11/14
09:05 am
ino
Inovio Pharmaceuticals (NASDAQ:INO) had its "overweight" rating reaffirmed by analysts at UBS Group AG.
Medium
Report
Inovio Pharmaceuticals (NASDAQ:INO) had its "overweight" rating reaffirmed by analysts at UBS Group AG.
11/14
09:05 am
ino
Inovio Pharmaceuticals (NASDAQ:INO) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
Medium
Report
Inovio Pharmaceuticals (NASDAQ:INO) had its "overweight" rating reaffirmed by analysts at Piper Sandler.
11/12
09:56 am
ino
Inovio 3Q25 Review: EPS Miss, $25M Offering, And INO-3107 Progress [Seeking Alpha]
Medium
Report
Inovio 3Q25 Review: EPS Miss, $25M Offering, And INO-3107 Progress [Seeking Alpha]
11/11
08:40 am
ino
INOVIO Announces Pricing of $25 Million Public Offering
Low
Report
INOVIO Announces Pricing of $25 Million Public Offering
11/11
12:30 am
ino
Inovio Pharmaceuticals Inc (INO) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
Low
Report
Inovio Pharmaceuticals Inc (INO) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ... [Yahoo! Finance]
11/10
06:09 pm
ino
INOVIO Announces Proposed Public Offering
Medium
Report
INOVIO Announces Proposed Public Offering
11/10
04:05 pm
ino
INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights
Medium
Report
INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights
11/10
10:01 am
ino
Here are the major earnings after the close Monday [Seeking Alpha]
Low
Report
Here are the major earnings after the close Monday [Seeking Alpha]
11/4
07:21 am
ino
Inovio Pharmaceuticals (NASDAQ:INO) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Inovio Pharmaceuticals (NASDAQ:INO) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..
11/3
08:05 am
ino
INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults
Medium
Report
INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults
10/31
04:53 pm
ino
INOVIO Reports Inducement Grant Under Inducement Plan
Medium
Report
INOVIO Reports Inducement Grant Under Inducement Plan
10/27
08:05 am
ino
INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025
Low
Report
INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025
10/23
04:05 pm
ino
INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference
Medium
Report
INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference
10/21
08:05 am
ino
Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine
Medium
Report
Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine
10/2
08:05 am
ino
INOVIO Reports Inducement Grant Under Inducement Plan
Medium
Report
INOVIO Reports Inducement Grant Under Inducement Plan
9/25
08:05 am
ino
INOVIO to Participate in Upcoming Scientific Conferences
Medium
Report
INOVIO to Participate in Upcoming Scientific Conferences